Sector Analysis: Who Has the Most to Lose in a U.S. vs China Trade Dispute?

The U.S. – China trade dispute has been dominating headlines for months and shows no signs of easing anytime soon.  Worry and caution on behalf of both investors and corporate management has been widespread, and at this point, repetitive. This presents us with a unique opportunity to look for companies or sectors where gaps exist between positive expectations and Trade War risk.

How are we conducting the analysis?

We used the Query Insights feature in Amenity Viewer to identify positive earnings sentiment around China, tariffs, trade, etc. from earnings calls this past quarter.

Please note: This in no way represents investment advice. All transcript text provided by S&P Global Market Intelligence.

Where did the sentiment analysis lead us? The MedTech sector.

This industry was initially exempt from tariffs, but that exemption was lifted in September. In this most recent quarter, we saw a cluster of bullish commentary of China from MedTech companies.

One More Shoe to Drop in the Trade Dispute?

Could the current optimism be the prelude for future disappointment as the more recent tariffs take effect? Investors only need to look to the 2Q/3Q issues in the Auto sector, which have been hit by the double-whammy of direct tariffs in addition to raw material inflation.  

When we examined MedTech's underlying earnings sentiment, three common themes emerged:

1. Broad-based recent strength in China

2. Some acknowledgment of China trade issues

Which was more than offset by... 3. Optimism regarding the ability to side-step the tariff headwind.

We highlight representative management commentary below:
  • Varian Medical Systems: October 23, 2018

"The strength of our China business is outstanding. We had a double-digit growth rate in the fourth quarter, building on several years of market share growth, and we remain committed to our customers and maintaining our growth in China."

"We’re working through this U.S., China trade disputes. It’s very important to us that be resolved for lots of reasons. But from a market point of view, at least so far, we’re seeing a robust market environment as the government continues to invest in cancer services."

  • Waters Corporation: October 23, 2018

"Asia,our largest region in terms of revenue, was up 7% in the quarter and double-digit growth in China"

"The Chinese situation possible has some effect linked to the broader trade dynamics in China, but we have a robust overall global franchise in TA and expect that to bounce back in Q4."

"From a tariff standpoint,because the vast majority of our products come in from places other than the United States, we’ve seen less of a direct effect. I did mention earlier that the TA Instruments product line, which is the one product line for us that comes in from the United States, has seen some delays between the order and sales cycle or elongated sales cycle, whether or not that’s tied to trade type activities, we’re watching that closely  But when we step back and look at the big picture of China, when it all comes together, it’s been a very solid story all year long, and our current assumptions call for the continuation of that trend."

  • Becton, Dickinson and Company: November 6, 2018

"Growth in China was a strong 13.6% in the fourth quarter, bringing the total year growth rate to 13.2%. This was driven by double-digit growth across all 3 segments."

"We expect to have good performance across all of our business segments in China."

"Tariffs,we’re going to be working with our suppliers to resource the base.  Now that takes a while.  We won’t expect to see much more impact in ’18, but that would help mitigate the impact in ’19, and perhaps whatever we can mitigate actually becomes a tailwind for us."

  • Agilent: November 19, 2018

"The overall view of China was very positive for the quarter.  And as we look at next year, I think Bob and I were talking about this earlier.  We’re guiding – embedded in our guidance assumptions is high single-digit growth in China for next year.  And despite all the noise that’s out there,what’s really happening on the ground is a lot different."

  • Bio-Techne Corporation: October 30, 2018

"The war on terror between U.S. and China has had minimal impact on our growth in China and we don’t expect that to change."

  • Bruker: November 1, 2018

"Our China BSI order rates in the last 3 quarters have been quite robust. Year-to-date,through the third quarter, we’ve not seen any significant impact from the trade dispute between China and the U.S. on our financial performance."

  • Danaher: October, 18, 2018

"You’ve seen tremendous strength in our China business to this point. I mean, China was up double digits in the third quarter, and it was the seventh consecutive quarter of double-digit growth for us. So right now, we feel pretty good about where we are in China, but there’s certainly room for a little bit of caution relative to any, as I said, second derivative impact on growth coming out of those markets."

Join the Amenity Viewer Beta Program today to analyze earnings call transcriptions and enable you to spot outliers, identify critical insights, and understand key drivers.

Transcript text provided by S&P Global Market Intelligence.

Copyright ©2018. All rights reserved.

September 18, 2019

Sentiment Analysis: Updated Regional Bank Uncertainty Ahead of Fed Rate Decision

We follow up on our regional banks white paper, applying our NLP platform to the full set of earnings calls from regional banks this quarter to explore the state of uncertainty before an expected rate cut on September 18th. Our rationale for close scrutiny of regional bank earnings calls holds true since our last publication as we find deceptive commentary indicating there may be underlying uncertainty regarding headwinds to net interest margins.
September 10, 2019

Analysts and Executives Silent on California Consumer Privacy Act

Under four months until the implementation of the California Consumer Privacy Act, Amenity’s text analytics tools detect a concerning absence of commentary in quarterly earnings calls. Against the backdrop of GDPR’s recent history, we would expect significantly more focus in the Q&A between analysts and management teams. We use our platform to contextualize CCPA in the broader context of global data privacy reform.
July 30, 2019

Sentiment Analysis: Regional Banks Shaky Prior to the Fed's Interest Rate Decision

We use our NLP platform to analyze regional bank earnings calls and estimate economic uncertainty in advance of the Federal Reserve’s rate decision. We uncover elevated deception levels focused on margin topics related to interest rates and net interest income, revealing evasive and euphemistic language patterns.
July 24, 2019

Snapchat Earnings: Beyond the Headline a Look at Cost-Price

Snapchat's 2Q19 showed a turnaround moment with beats on user growth and revenue, but a look beyond the headlines through the lens of our text analytics platform shows that while Deception has tapered off SNAP's 1Q18 high, the trend in Cost-Price is worth a closer examination.

Stay Informed: Join Our Newsletter

Keep up to date with our analyses and how we're making changes.